Period Ending | Dec 30, 2012 | Dec 30, 2011 |
---|
Total Revenue
|
16,311,000
|
16,049,000
| Cost of Revenue | 11,448,000 | 11,261,000 | |
Gross Profit
|
4,863,000
|
4,788,000
| |
|
Operating Expenses |
|
Research Development | 439,000 | 417,000 |
|
Selling General and Administrative | 2,894,000 | 2,738,000 |
|
Non Recurring |
-
|
-
|
|
Others |
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
| | |
Operating Income or Loss
|
1,530,000
|
1,633,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (71,000) | 38,000 |
|
Earnings Before Interest And Taxes | 1,459,000 | 1,671,000 |
|
Interest Expense | 208,000 | 118,000 |
|
Income Before Tax | 1,251,000 | 1,553,000 |
|
Income Tax Expense | 31,000 | 201,000 |
|
Minority Interest | (3,000) | (2,000) |
|
|
|
Net Income From Continuing Ops | 1,217,000 | 1,350,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
|
Extraordinary Items |
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
|
Other Items |
-
|
-
| | |
Net Income
|
1,217,000
|
1,350,000
| Preferred Stock And Other Adjustments |
-
|
-
| |
Net Income Applicable To Common Shares
|
1,217,000
|
1,350,000
|
|